Slam dunk! Third jab a boost for transplant patients
A month after a third shot, 55% developed antibody levels likely to provide notable protection, study finds
A third dose of Moderna’s vaccine significantly raised antibody levels against the coronavirus in transplant patients, according a comparison of an extra shot to a placebo in people with weak immune systems.
The results could be influential. Transplant patients and others with compromised immunity often don’t get adequate responses to their first vaccine course and are at the top of the list for getting potential Covid-19 boosters. An advisory committee to the US Centers for Disease Control and Prevention (CDC) is set to discuss the possibility of booster shots for immune-compromised people on Friday.
The new study of 120 transplant patients looked at the effects of a third dose that was given two months after the second. A month after the third shot, 55% of those who got it developed antibody levels likely to provide significant protection...